Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE

Xu S, Duan H, An Y, et al. Vaccine. 2023;41(17):2793-2803. doi:10.1016/j.vaccine.2023.03.035

VFI headquarters and Geneva laboratories

Rue du Champ-Blanchod 4
1228 Plan-les-Ouates
Switzerland

VFI Lausanne laboratories

Route de la Corniche 5
1066 Epalinges
Switzerland

contact@vformulation.org
VFI on LinkedIn

© 2025 Vaccine Formulation Institute